Ligand validation:8UFR

WK2: (7M)-4-methyl-7-(4-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)quinolin-2-amine

WK2 is a Ligand Of Interest in 8UFR designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8UFR_WK2_D_503	59%	18%	0.145	0.927	0.99	2.52	-	12	2	0	100%	1
8UFR_WK2_B_503	46%	25%	0.166	0.903	0.97	2.07	-	9	2	0	100%	1
8UFR_WK2_A_503	15%	16%	0.325	0.887	1.07	2.54	2	10	2	0	100%	1
8UFR_WK2_C_503	14%	21%	0.317	0.875	1.02	2.28	1	13	1	0	100%	1
8UFT_WK2_B_504	55%	42%	0.151	0.918	0.98	1.27	-	4	2	0	100%	1
8UFP_WK2_B_802	70%	31%	0.129	0.947	1.02	1.7	2	5	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.